Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
Gilead Sciences, Inc. (GILD) will release its first quarter 2024 financial results and guidance on April 25, 2024. A webcast will be hosted to discuss the results and provide a business update.
04/08/2024 - 04:05 PM
FOSTER CITY, Calif. --(BUSINESS WIRE)--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2024 financial results and guidance will be released on Thursday, April 25, 2024, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s first quarter 2024 financial results and provide a business update.
A live webcast will be available on the Investor Relations section of www.gilead.com and will be archived there for one year.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California .
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240408350262/en/
Jacquie Ross, CFA – Investors
investor_relations@gilead.com
Source: Gilead Sciences, Inc.
When will Gilead Sciences release its first quarter 2024 financial results and guidance?
Gilead Sciences will release its first quarter 2024 financial results and guidance on Thursday, April 25, 2024, after the market closes.
What time will the webcast to discuss the first quarter 2024 financial results be held?
The webcast to discuss the first quarter 2024 financial results will be held at 4:30 p.m. Eastern Time on April 25, 2024.
Where can investors watch the live webcast?
Investors can watch the live webcast on the Investor Relations section of www.gilead.com.
GILD Rankings
#2131 Ranked by Stock Gains
GILD Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Biotechnology, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Foster City
About GILD
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir.